标题
Specific immunotherapy in ovarian cancer: a systematic review
作者
关键词
-
出版物
Immunotherapy
Volume 8, Issue 10, Pages 1193-1204
出版商
Future Medicine Ltd
发表日期
2016-09-08
DOI
10.2217/imt-2016-0034
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
- (2015) Francesca De Felice et al. Journal of Immunology Research
- Immunotherapeutic approaches to ovarian cancer treatment
- (2015) Cariad Chester et al. Journal for ImmunoTherapy of Cancer
- Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival—a substudy of the MIMOSA trial
- (2014) Alexia Buzzonetti et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Better Therapeutic Trials in Ovarian Cancer
- (2014) M. A. Bookman et al. JNCI-Journal of the National Cancer Institute
- Targeted therapies and clinical trials in ovarian cancer
- (2013) J. Dancey ANNALS OF ONCOLOGY
- New developments in the treatment of ovarian cancer--future perspectives
- (2013) J. Lopez et al. ANNALS OF ONCOLOGY
- Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives
- (2013) A. Milani et al. ANNALS OF ONCOLOGY
- Antibody-based immunotherapy for ovarian cancer: where are we at?
- (2013) B. W. C. Tse et al. ANNALS OF ONCOLOGY
- New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
- (2013) S. Banerjee et al. CLINICAL CANCER RESEARCH
- Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study
- (2013) Paul Sabbatini et al. JOURNAL OF CLINICAL ONCOLOGY
- Active Immunotherapy: Current State of the Art in Vaccine Approaches for NHL
- (2012) M. Lia Palomba Current Oncology Reports
- Overview of the cancer vaccine field
- (2012) Alex Kudrin et al. Human Vaccines & Immunotherapeutics
- Immunotherapy in ovarian cancer
- (2012) Gina M. Mantia-Smaldone et al. Human Vaccines & Immunotherapeutics
- A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer
- (2011) M. Mohebtash et al. CLINICAL CANCER RESEARCH
- The Epidemiology of Endometrial and Ovarian Cancer
- (2011) Daniel W. Cramer HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer
- (2011) Rachel N Grisham et al. Immunotherapy
- Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites
- (2011) Marion G. Ott et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term clinical and immunological effects of p53-SLP® vaccine in patients with ovarian cancer
- (2011) Ninke Leffers et al. INTERNATIONAL JOURNAL OF CANCER
- Improvement of different vaccine delivery systems for cancer therapy
- (2011) Azam Bolhassani et al. Molecular Cancer
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
- (2010) Markus M. Heiss et al. INTERNATIONAL JOURNAL OF CANCER
- Strategies for Cancer Vaccine Development
- (2010) Matteo Vergati et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer
- (2008) Angèle L.M. Oei et al. INTERNATIONAL JOURNAL OF CANCER
- Oregovomab Maintenance Monoimmunotherapy Does Not Improve Outcomes in Advanced Ovarian Cancer
- (2008) Jonathan Berek et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now